N H Rasmussen1, J Dal2, F de Vries3,4, J P van den Bergh5,6,7, M H Jensen8, P Vestergaard8. 1. Steno Diabetes Center North, Aalborg University Hospital, Aalborg, Denmark. nicklas.rasmussen@rn.dk. 2. Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark. 3. Department of Clinical Pharmacy & Toxicology, Maastricht UMC+, Maastricht, The Netherlands. 4. Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. 5. Department of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands. 6. Department of Internal Medicine, Maastricht UMC+, Maastricht, The Netherlands. 7. Faculty of Medicine and Life Sciences, University Hasselt, Hasselt, Belgium. 8. Steno Diabetes Center North, Aalborg University Hospital, Aalborg, Denmark.
Abstract
Patients with diabetes have an increased risk of fractures. In this study, subtrochanteric and femoral shaft fractures were increased in patients with type 1 diabetes compared with the general population. In the light of this, more evidence points towards an association between diabetes and atypical femoral fractures. INTRODUCTION: Patients with diabetes have an increased risk of femoral fractures, but little is known about the risk of atypical femoral fractures (AFFs). The aim of this study was to identify the risk of subtrochanteric and femoral shaft (ST/FS) fractures and estimate the risk of AFFs in patients with type 1 (T1D) and type 2 diabetes (T2D). METHODS: From the nationwide Danish National Patient Register, we identified patients with T1D (n = 19,896), T2D (n = 312,188), and sex- and aged-matched controls without diabetes (n = 996,252) from the general population and all ST/FS fractures (n = 7509). Data were analyzed using a Cox proportional-hazards model and the incidence rate and rate ratio of ST/FS fractures were estimated. RESULTS: The incidence rate of ST/FS fractures in T1D was 52.14 events per 100,000 person years and 73.21 per 100,000 person years in T2D. T1D was associated with an increased risk of ST/FS (HR 2.07 (95% CI 1.68-2.56)), whereas T2D was not (HR 0.99 (95% CI 0.94-1.10)). Previous ST/FS fractures were associated with an increased risk of subsequent ST/FS fractures (HR 6.95 (95% CI 6.00-8.05)) and the use of bisphosphonates with an increased risk of ST/FS fractures (HR 1.72 (95% CI 1.54-1.91)). CONCLUSION: Patients with T1D have a higher risk of ST/FS fractures compared with sex- and age-matched controls. Since a proportion of ST/FS fractures are classified as AFFs, this could point towards the fact that AFFs also are increased in patients with T1D, but not T2D.
Patients with diabetes have an increased risk of fractures. In this study, subtrochanteric and femoral shaft fractures were increased in patients with type 1 diabetes compared with the general population. In the light of this, more evidence points towards an association between diabetes and atypical femoral fractures. INTRODUCTION:Patients with diabetes have an increased risk of femoral fractures, but little is known about the risk of atypical femoral fractures (AFFs). The aim of this study was to identify the risk of subtrochanteric and femoral shaft (ST/FS) fractures and estimate the risk of AFFs in patients with type 1 (T1D) and type 2 diabetes (T2D). METHODS: From the nationwide Danish National Patient Register, we identified patients with T1D (n = 19,896), T2D (n = 312,188), and sex- and aged-matched controls without diabetes (n = 996,252) from the general population and all ST/FS fractures (n = 7509). Data were analyzed using a Cox proportional-hazards model and the incidence rate and rate ratio of ST/FS fractures were estimated. RESULTS: The incidence rate of ST/FS fractures in T1D was 52.14 events per 100,000 person years and 73.21 per 100,000 person years in T2D. T1D was associated with an increased risk of ST/FS (HR 2.07 (95% CI 1.68-2.56)), whereas T2D was not (HR 0.99 (95% CI 0.94-1.10)). Previous ST/FS fractures were associated with an increased risk of subsequent ST/FS fractures (HR 6.95 (95% CI 6.00-8.05)) and the use of bisphosphonates with an increased risk of ST/FS fractures (HR 1.72 (95% CI 1.54-1.91)). CONCLUSION:Patients with T1D have a higher risk of ST/FS fractures compared with sex- and age-matched controls. Since a proportion of ST/FS fractures are classified as AFFs, this could point towards the fact that AFFs also are increased in patients with T1D, but not T2D.
Entities:
Keywords:
Atypical femoral fractures; Diabetes type 1; Diabetes type 2; Femoral shaft fracture; Fractures; Subtrochanteric fracture
Authors: Andrea Giusti; Neveen A T Hamdy; Olaf M Dekkers; Sharita R Ramautar; Sander Dijkstra; Socrates E Papapoulos Journal: Bone Date: 2010-12-31 Impact factor: 4.398
Authors: Morten Schmidt; Sigrun Alba Johannesdottir Schmidt; Jakob Lynge Sandegaard; Vera Ehrenstein; Lars Pedersen; Henrik Toft Sørensen Journal: Clin Epidemiol Date: 2015-11-17 Impact factor: 4.790
Authors: V Van Hulten; Nicklas Rasmussen; J H M Driessen; A M Burden; A Kvist; J P van den Bergh Journal: Curr Osteoporos Rep Date: 2021-12-21 Impact factor: 5.096
Authors: Veerle van Hulten; Cindy Sarodnik; Johanna H M Driessen; Nicolaas C Schaper; Piet P M M Geusens; Carol A B Webers; Geert-Jan Dinant; Ramon P G Ottenheijm; Nicklas H Rasmussen; Rikke Viggers; Coen D A Stehouwer; Carla J H van der Kallen; Miranda T Schram; Sandrine P G Bours; Pieter C Dagnelie; Joop P van den Bergh Journal: Front Endocrinol (Lausanne) Date: 2022-02-18 Impact factor: 5.555
Authors: George F Georgiadis; Dimitrios G Begkas; Konstantinos A Maniatis; Alexandros E Vasilakis; Stamatios Theodoros D Chatzopoulos; Alexia P Balanika Journal: J Orthop Case Rep Date: 2021-10